A phase II trial of bevacizumab and everolimus as treatment for patients with refractory, progressive intracranial meningioma Article

cited authors

  • Shih, Kent C.; Chowdhary, Sajeel; Rosenblatt, Paul; Weir, Alva B., III; Shepard, Gregg C.; Williams, Jeffrey T.; Shastry, Mythili; Burris, Howard A., III; Hainsworth, John D.

Publication Date

  • September 1, 2016

webpage

published in

category

keywords

  • Bevacizumab
  • Everolimus
  • Meningioma

start page

  • 281

end page

  • 288

volume

  • 129

issue

  • 2